Pages that link to "Q36926655"
Jump to navigation
Jump to search
The following pages link to The prognostic value of nestin expression in newly diagnosed glioblastoma: report from the Radiation Therapy Oncology Group (Q36926655):
Displaying 25 items.
- Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone (Q33599056) (← links)
- TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients (Q33653031) (← links)
- Herpes simplex virus oncolytic therapy for pediatric malignancies (Q33713824) (← links)
- Molecular pathology in adult high‐grade gliomas: from molecular diagnostics to target therapies (Q33925544) (← links)
- Clinical value of CD133 and nestin in patients with glioma: a population-based study (Q34028947) (← links)
- Prognostic value of glioma cancer stem cell isolation in survival of primary glioblastoma patients. (Q34785641) (← links)
- High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas (Q35077834) (← links)
- Radiosensitization of Primary Human Glioblastoma Stem-like Cells with Low-Dose AKT Inhibition. (Q35587475) (← links)
- Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics (Q36104523) (← links)
- The availability of the embryonic TGF-β protein Nodal is dynamically regulated during glioblastoma multiforme tumorigenesis (Q37018171) (← links)
- B7-H4 expression is elevated in human U251 glioma stem-like cells and is inducible in monocytes cultured with U251 stem-like cell conditioned medium (Q37409770) (← links)
- Combining drugs and radiotherapy: from the bench to the bedside (Q37601254) (← links)
- What is the clinical value of cancer stem cell markers in gliomas? (Q38081776) (← links)
- Molecular prognostic factors in glioblastoma: state of the art and future challenges (Q38233134) (← links)
- The presence of stem cell marker‐expressing cells is not prognostically significant in glioblastomas (Q38477694) (← links)
- Nestin Expression Is Associated with Poor Clinicopathological Features and Prognosis in Glioma Patients: an Association Study and Meta-analysis (Q38696948) (← links)
- TLR9 expression is associated with prognosis in patients with glioblastoma multiforme (Q39428612) (← links)
- The Role of Cancer Stem Cells (CD133 ) in Malignant Gliomas (Q45863982) (← links)
- NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients (Q48100633) (← links)
- Nestin expression in brain tumors: its utility for pathological diagnosis and correlation with the prognosis of high-grade gliomas (Q48650775) (← links)
- Clinicopathological significance of expression of nestin, a neural stem/progenitor cell marker, in human glioma tissue (Q48887298) (← links)
- Prognostic value of Musashi-1 in gliomas. (Q55461475) (← links)
- Pathological characterization of the glioblastoma border as shown during surgery using 5-aminolevulinic acid-induced fluorescence (Q55463356) (← links)
- Nestin involvement in tissue injury and cancer--a potential tumor marker? (Q87676067) (← links)
- Expression of markers of neural stem and progenitor cells in glioblastoma multiforme in relation to tumor recurrence and overall survival (Q90447376) (← links)